Showing results (281-290 of 1,899) with videos related to
Sort By:
Pageof 190
Current Neuropharmacology|January 14, 2021
PTSD in the COVID-19 EraFarah Chamaa, Hisham F Bahmad, Batoul Darwish, et al.Current Neuropharmacology|January 14, 2021
Crosstalk Between Covid-19 and Associated Neurological Disorders: A ReviewAnu K Ramachandran, Subham Das, Alex JosephCurrent Neuropharmacology|November 3, 2016
Pros and Cons of Medical Cannabis use by People with Chronic Brain DisordersUma Suryadevara, Dawn M Bruijnzeel, Meena Nuthi, et al.Current Neuropharmacology|March 2, 2019
Association between Serum Lipids and Antipsychotic Response in SchizophreniaDavid D Kim, Alasdair M Barr, Diane H Fredrikson, et al.Current Neuropharmacology|March 16, 2017
The Infectious Etiology of Alzheimer's DiseaseMarta Sochocka, Katarzyna Zwolińska, Jerzy LeszekCurrent Neuropharmacology|February 24, 2017
Beyond Ketamine: New Approaches to the Development of Safer AntidepressantsShigeyuki ChakiCurrent Neuropharmacology|March 31, 2017
Calcium-engaged Mechanisms of Nongenomic Action of NeurosteroidsElzbieta Rebas, Tomasz Radzik, Tomasz Boczek, et al.Current Neuropharmacology|August 1, 2019
Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative DiseasesLing-Shuang Zhu, Ding-Qi Wang, Ke Cui, et al.Current Neuropharmacology|December 31, 2016
In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic AcidRajeev K Singla, Luciana Scotti, Ashok K DubeyCurrent Neuropharmacology|February 18, 2014
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's DiseaseAngel Agis-Torres, Monica Sölhuber, Maria Fernandez, et al.Pageof 190